{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:14:28Z","timestamp":1786947268905,"version":"build-2736575974"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004801","name":"Shota Rustaveli National Science Foundation","doi-asserted-by":"publisher","award":["FR-22-971"],"award-info":[{"award-number":["FR-22-971"]}],"id":[{"id":"10.13039\/501100004801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jpba.2024.116076","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T11:25:55Z","timestamp":1709033155000},"page":"116076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Optimization of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids"],"prefix":"10.1016","volume":"243","author":[{"given":"Giorgia","family":"Sprega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgi","family":"Kobidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Fabrizio","family":"Lo Faro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tivadar","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasio","family":"Tini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Mskhiladze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Busard\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bezhan","family":"Chankvetadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116076_bib1","unstructured":"\u3008https:\/\/nida.nih.gov\/publications\/research-reports\/mdma-ecstasy-abuse\/what-is-the-scope-of-mdma-use-in-the-united-states\u3009."},{"key":"10.1016\/j.jpba.2024.116076_bib2","unstructured":"\u3008https:\/\/www.theguardian.com\/australia-news\/2023\/jul\/01\/australian-psychiatrists-can-now-prescribe-mdma-and-psilocybin-who-can-access-them-and-how-do-they-work\u3009."},{"key":"10.1016\/j.jpba.2024.116076_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00007691-200404000-00008","article-title":"The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity","volume":"26","author":"Monks","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2024.116076_bib4","first-page":"917","article-title":"The pharmacology and toxicology of \u201cecstasy\u201d (MDMA) and related drugs","volume":"165","author":"Kalant","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.jpba.2024.116076_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1360-0443.1994.tb03330.x","article-title":"3,4-Methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d): pharmacology and toxicology in animals and humans","volume":"89","author":"Steele","year":"1994","journal-title":"Addiction"},{"key":"10.1016\/j.jpba.2024.116076_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00007691-200204000-00009","article-title":"Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, of amphetamine, methamphetamine and their N-alkyl derivatives","volume":"24","author":"Kraemer","year":"2002","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2024.116076_bib7","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/clinchem\/45.7.1058","article-title":"Stereospecific analysis and enantiomeric disposition of 3,4-methylenedioxymethamphetamine (Ecstasy) in humans","author":"Fallon","year":"1999","journal-title":"Clin. Chem. 45"},{"key":"10.1016\/j.jpba.2024.116076_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0378-4347(00)82761-9","article-title":"Determination of 3.4-methelenedioxyamphetamine and 3,4-methylenedioxymethamphetamine enantiomers in whole blood","volume":"490","author":"Fitzgerald","year":"1989","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2024.116076_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/chir.530020409","article-title":"Stereoselective pharmacokinetics of 3,4-methylenedioxymethamphetamine in the rat","volume":"2","author":"Fitzgerald","year":"1990","journal-title":"Chirality"},{"key":"10.1016\/j.jpba.2024.116076_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jat\/bkw005","article-title":"Improved Chiral Separation of methamphetamine enantiomers using CSP-LC\u2013MS-MS","volume":"40","author":"Ward","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116076_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115768","article-title":"Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for quantitative determination of 3,4-methylenedioxymethamphetamine (MDMA) and some of its metabolites in human biological samples","volume":"238","author":"Lo Faro","year":"2024","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852400116X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852400116X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:46:49Z","timestamp":1778539609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170852400116X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":11,"alternative-id":["S073170852400116X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116076","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116076"}}